• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells.

作者信息

Ragno P, Montuori N, Rossi G

机构信息

Centro di Endocrinologia ed Oncologia Sperimentale (CEOS), Consiglio Nazionale delle Ricerche, Naples, Italy.

出版信息

Biochem Biophys Res Commun. 1996 Jul 5;224(1):252-7. doi: 10.1006/bbrc.1996.1016.

DOI:10.1006/bbrc.1996.1016
PMID:8694822
Abstract

The monocyte-like THP-1 cells express on their surface the urokinase-type plasminogen activator receptor (uPA-R). This receptor, chemically cross-linked to its possible ligands, migrates, in SDS PAGE, slower than the uPA-R expressed on the epithelial thyroid cell line TAD-2, cross-linked to the same ligands. The different migration corresponds to a difference in molecular weight of 15 kDa. Similar results were obtained with peripheral monocytes and primary cultures of thyroid cells. The molecular weight of the native receptor is about 50 kDa and appears to be identical in these two cell types. Such results suggest that, in monocytic cells, uPA-R associates to a 15 kDa molecule. This molecule is probably linked to the cell surface by a glyco-phospho-inositol anchor since, by phospholipase-C treatment, it is co-eluted with the urokinase-type plasminogen activator receptor from THP-1 cells.

摘要

相似文献

1
Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells.
Biochem Biophys Res Commun. 1996 Jul 5;224(1):252-7. doi: 10.1006/bbrc.1996.1016.
2
Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells.尿激酶型纤溶酶原激活剂受体截短形式在正常和肿瘤甲状腺细胞中的差异表达。
Cancer Res. 1998 Mar 15;58(6):1315-9.
3
Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.受体介导的纤溶酶原激活物功能调节:两种直接膜锚定形式的尿激酶对纤溶酶原的激活作用
J Pept Sci. 2000 Sep;6(9):432-9. doi: 10.1002/1099-1387(200009)6:9<432::AID-PSC279>3.0.CO;2-Q.
4
Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.尿激酶型纤溶酶原激活剂/2型纤溶酶原激活剂抑制剂复合物与THP-1细胞中的尿激酶型纤溶酶原激活剂受体结合后不会被内化。尿激酶型纤溶酶原激活剂/2型纤溶酶原激活剂抑制剂复合物与细胞表面的相互作用。
Eur J Biochem. 1995 Oct 15;233(2):514-9. doi: 10.1111/j.1432-1033.1995.514_2.x.
5
Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.肾细胞癌患者中尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂受体和纤溶酶原激活剂抑制剂的表达:与肿瘤相关巨噬细胞及预后的相关性
J Urol. 2005 Aug;174(2):461-5. doi: 10.1097/01.ju.0000165150.46006.92.
6
Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂受体及其抑制剂在春季角结膜炎中的作用
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70. doi: 10.1167/iovs.04-1196.
7
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.尿激酶型纤溶酶原激活物受体(uPAR)在血液和骨髓细胞上的结构、功能及表达
Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398.
8
Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.早期胎盘形成过程中恒河猴妊娠子宫中尿激酶、纤溶酶原激活物抑制剂及尿激酶受体的表达
Placenta. 2000 Mar-Apr;21(2-3):184-93. doi: 10.1053/plac.1999.0446.
9
cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.
J Immunol. 1992 Jun 1;148(11):3636-42.
10
Processing of complex between urokinase and its type-2 inhibitor on the cell surface. A possible regulatory mechanism of urokinase activity.
FEBS Lett. 1993 Jun 1;323(3):279-84. doi: 10.1016/0014-5793(93)81357-6.

引用本文的文献

1
The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors.肥大细胞中的尿激酶/尿激酶受体系统:其与fMLF受体功能相互作用的影响。
Transl Med UniSa. 2016 Nov 1;15:34-41. eCollection 2016 Nov.